Vident Advisory, LLC Exact Sciences Corp Transaction History
Vident Advisory, LLC
- $4.8 Trillion
- Q1 2024
A detailed history of Vident Advisory, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Vident Advisory, LLC holds 15,396 shares of EXAS stock, worth $720,686. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,396
Previous 28,177
45.36%
Holding current value
$720,686
Previous $2.08 Billion
48.99%
% of portfolio
0.02%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
697Shares Held
160MCall Options Held
5.81MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$830 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$610 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$580 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$533 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$500 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.28B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...